Drug profile · INN
autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor (sipuleucel-t)
PROVENGE
- Patents linked
- 0
- News articles
- 0
Quick answer
autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor (sipuleucel-t) (PROVENGE) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor (sipuleucel-t)
Brand PROVENGE
ATC code L03AX17
Frequently asked questions
What is autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor (sipuleucel-t)?
autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor (sipuleucel-t) (PROVENGE) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor (sipuleucel-t)?
PROVENGE is a marketed brand name for autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor (sipuleucel-t). Check FDA Drugs@FDA for the current US label holder and prescribing information.